{{Rsnum
|rsid=4846033
|Chromosome=1
|position=11728507
|Orientation=plus
|GMAF=0.04775
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 1.6 | 98.4
| HCB | 0.0 | 5.8 | 94.2
| JPT | 0.0 | 0.9 | 99.1
| YRI | 1.4 | 29.2 | 69.4
| ASW | 3.5 | 26.3 | 70.2
| CHB | 0.0 | 5.8 | 94.2
| CHD | 0.0 | 3.7 | 96.3
| GIH | 0.0 | 1.0 | 99.0
| LWK | 1.9 | 28.0 | 70.1
| MEX | 0.0 | 0.0 | 0.0
| MKK | 1.3 | 27.7 | 71.0
| TSI | 0.0 | 2.9 | 97.1
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs4846033
|PubMedID=18347602
|Condition=Schizophrenia
|Gene=Intergenic
|Risk Allele=
|pValue=4.00E-006
|OR=2.87
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs4846033
|Name_s=
|Gene_s=C1orf187, AGTRAP
|Feature=
|Evidence=PubMed ID:18347602; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genomewide association for schizophrenia in the CATIE study: results of stage 1 (Initial Sample Size: 738 cases, 733 controls; Replication Sample Size: NR). This variant is associated with Schizophrenia.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356464
}}

{{PMID Auto
|PMID=20485477
|Title=New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia?
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4846033
|overall_frequency_n=114
|overall_frequency_d=126
|overall_frequency=0.904762
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=95
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}